Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adenoassociated viruses

60Citations
Citations of this article
139Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent advances using CRISPR-Cas9 approaches have dramatically enhanced the ease for genetic manipulation in rodents. Notwithstanding, the methods to deliver nucleic acids into pre-implantation embryos have hardly changed since the original description of mouse transgenesis more than 30 years ago. Here we report a novel strategy to generate genetically modified mice by transduction of CRISPR-Cas9 components into pre-implantation mouse embryos via recombinant adeno-Associated viruses (rAAVs). Using this approach, we efficiently generated a variety of targeted mutations in explanted embryos, including indel events produced by non-homologous end joining and tailored mutations using homology-directed repair. We also achieved gene modification in vivo by direct delivery of rAAV particles into the oviduct of pregnant females. Our approach greatly simplifies the generation of genetically modified mice and, more importantly, opens the door for streamlined gene editing in other mammalian species.

Cite

CITATION STYLE

APA

Yoon, Y., Wang, D., Tai, P. W. L., Riley, J., Gao, G., & Rivera-Pérez, J. A. (2018). Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adenoassociated viruses. Nature Communications, 9(1). https://doi.org/10.1038/s41467-017-02706-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free